Premium
Silent but deadly: patients with enterococcal bacteraemia should be assessed for colorectal neoplasia
Author(s) -
Athan Eugene,
Cabiltes Ivana,
Coghill Sarah,
Bowe Steven J
Publication year - 2019
Publication title -
medical journal of australia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 131
eISSN - 1326-5377
pISSN - 0025-729X
DOI - 10.5694/mja2.12027
Subject(s) - medicine , streptococcus bovis , bacteremia , enterococcus faecalis , epidemiology , colorectal cancer , infective endocarditis , colonoscopy , enterococcus , endocarditis , incidence (geometry) , cancer , staphylococcus aureus , antibiotics , rumen , chemistry , genetics , food science , optics , physics , fermentation , bacteria , microbiology and biotechnology , biology
The epidemiology of bloodstream infections has changed during the early 21st century, and our understanding of complex host–pathogen relationships continues to evolve. Enterococci have emerged as major community and health care pathogens; the association of colorectal neoplasia with enterococcal infections has recently been reported, particularly with communityacquired Enterococcus faecalis bacteraemia of unknown source.1,2